Combivent Sales Data
| Rank 54 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Combivent U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 54 ( 1) |
$266,777 | 0.65% | 1,765 | -1.89% |
| Q4 2012 | 53 ( 1) |
$265,042 | -0.14% | 1,799 | -6.69% |
| Q3 2012 | 54 (1) |
$265,411 | -1.79% | 1,928 | 1.26% |
| Q2 2012 | 53 (1) |
$270,254 | -5.34% | 1,904 | -4.23% |
| Q1 2012 | 52 | $285,487 | 1.08% | 1,988 | -1.29% |
| Q4 2011 | 52 (4) |
$282,423 | 10.49% | 2,014 | 2.03% |
| Q3 2011 | 56 (1) |
$255,615 | -0.53% | 1,974 | -6.36% |
| Q2 2011 | 57 (1) |
$256,985 | -1.62% | 2,108 | -2.86% |
| Q1 2011 | 58 | $261,226 |  |
2,170 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| April 14, 2010 | Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available |
